Back to results
US 2021/0171575 A1Published application
Solution phase routes for wnt hexapeptides
AssigneeWntresearch AB
InventorDennis HENRIKSEN
Life of this patent
Estimating the term…
Abstract
The present disclosure relates generally to the field of polypeptide synthesis, and more particularly, to the solution phase synthesis of the Wnt hexapeptide Foxy-5 and protected derivatives and peptide fragments thereof.
Claims6
A protected peptide fragment of Foxy-5 (For-Met-Asp-Gly-Cys-Glu-Leu-OH) selected from
- a. PG1-Gly-Cys(PG2)-Glu(OPG3)-Leu-OR1
- b. PG1-Asp(OPG3)-Gly-Cys(PG2)-Glu(OPG3)-Leu-OR1
- c. PG1-Met-Asp(OPG3)-Gly-Cys(PG2)-Glu(OPG3)-Leu-OR1
- d. For-Met-Asp(OPG3)-Gly-Cys(PG2)-Glu(OPG3)-Leu-OR1,
- wherein PG1 is selected from H and base sensitive protecting groups such as fluorenylmethyl-oxycarbonyl (Fmoc), PG2 is selected from H and trityl (Trt), PG3 is selected from H and Cert-butyl (tBu), and R1 is chosen from H and C1-C6 alkyl, such as methyl, ethyl or Cert-butyl (tBu) with the proviso that PG1, PG2, PG3 and R1 are not simultaneously hydrogen.
2 more elements
A solution phase method for preparing a protected derivative of Foxy-5, PG1-Met-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu, the method comprising:
- a. Sequentially coupling tripeptide Fmoc-Cys(Trt)Glu(OtBu)-Leu-OtBu (KT-2*) with Fmoc-Gly-OH, Fmoc-Asp-OtBu and PG1-Met, or
- b. Sequentially coupling tetrapeptide Fmoc-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu (SEQ_ID NO 6) with Fmoc-Asp-OtBu and PG1-Met,
- wherein
- i. Fmoc deprotection is achieved with DBU, and wherein
- ii. DBU is removed from the reaction mass before coupling with Fmoc-Asp-OtBu, and wherein
- iii. PG1 is a base sensitive protecting group such as Fmoc.
3 more elements
A solution phase method for converting PG1-Met-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu to Foxy-5 (For-Met-Asp-Gly-Cys-Glu-Leu-OH), the method comprising:
- i. Removal of PG1 from hexapeptide PG1-Met-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu followed by coupling with formic acid to yield For-Met-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu (SEQ_NO 15),
- ii. Deprotection of For-Met-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu (SEQ_NO 15) to afford Foxy-5 in crude form,
- followed by:
- a. Optional purification of the crude product by column chromatography, optionally followed by precipitation as a solid from an organic solvent,
- b. Optional precipitation of the formed Foxy-5 hexapeptide as an alkaline or acidic salt in solid form, such as in crystalline form.
2 more elements
Dependencies are inferred from the claim text.